TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Danamedicus AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,595
|
1,548
|
1,307 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
647
|
542
|
381 |
EBITDA |
613
|
530
|
372 |
Total assets |
2,154
|
2,021
|
1,900 |
Current assets |
2,154
|
2,021
|
1,900 |
Current liabilities |
132
|
109
|
143 |
Equity capital |
1,938
|
1,828
|
1,702 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.0%
|
90.5%
|
89.6% |
Turnover per employee |
798
|
774
|
654 |
Profit as a percentage of turnover |
40.6%
|
35.0%
|
29.2% |
Return on assets (ROA) |
30.0%
|
26.8%
|
20.1% |
Current ratio |
1631.8%
|
1854.1%
|
1328.7% |
Return on equity (ROE) |
33.4%
|
29.6%
|
22.4% |
Change turnover |
47
|
241
|
-222 |
Change turnover % |
3%
|
18%
|
-15% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.